Evidence map›Paper›PMID 39896756›Full record

ArticleMedComm2025

Outer membrane vesicle contributes to the

Yingzhou Xie, Yi-Han Shi, Le-Le Wang, Cheng-Wei Li, Min Wu, Jin-Fu Xu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in MedComm, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Targeting Outer Membrane Vesicles ofJournal of microbiology and biotechnology · 2026
    Review
  2. Review
  3. Microbial extracellular vesicles in the lung: friends in health, agents in disease.Extracellular vesicles and circulating nucleic acids · 2026
    Review
  4. Review
  5. Review
  6. Ability of Linezolid to CombatAntibiotics (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Microbiome and its role in bronchiectasis.Therapeutic advances in respiratory disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yingzhou XieShanghai Pulmonary Hospital, Institute of Respiratory Medicine, School of Medicine Tongji University Shanghai China.
Yi-Han ShiShanghai Pulmonary Hospital, Institute of Respiratory Medicine, School of Medicine Tongji University Shanghai China.
Le-Le WangShanghai Pulmonary Hospital, Institute of Respiratory Medicine, School of Medicine Tongji University Shanghai China.
Cheng-Wei LiDepartment of Pulmonary and Critical Care Medicine Huashan Hospital, Fudan University Shanghai China.
Min WuDepartment of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Wenzhou Medical University, and Wenzhou Institute University of Chinese Academy of Sciences Wenzhou China.
Jin-Fu XuShanghai Pulmonary Hospital, Institute of Respiratory Medicine, School of Medicine Tongji University Shanghai China.ORCID https://orcid.org/0000-0002-8039-8973

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

2‐heptyl‐4‐quinoloneantimicrobial peptides resistancebronchiectasislactateouter membrane vesiclesPseudomonas aeruginosa

Identifiers

PMID39896756
PMCPMC11782972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.